cerca CERCA
Domenica 28 Febbraio 2021
Aggiornato: 14:22
Temi caldi

chimica_e_farmacia salute_e_benessere chimica_e_farmacia altro ict media_e_pubblicita chimica_e_farmacia

Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A

LACHEN, Switzerland, Feb. 22, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. "Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study" https://www.thieme-connect.com/products/ejournals/abstra...

ora in
Prima pagina
articoli
in Evidenza